-
Voliotis Dimitris
2023/04/20
SVP, Clinical Development
119563
-30601
2023-04-20
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/19
1450000
-500000
2023-04-19
0001725160
0001725160
950000
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/18
1450000
-500000
2023-04-18
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/17
SVP, Clinical Development
119563
-30601
2023-04-17
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/16
1450000
-500000
2023-04-16
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/15
SVP, Clinical Development
119563
-30601
2023-04-15
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/04/14
Chief Financial Officer
459293
-94611
2023-04-14
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/04/13
SVP, Clinical Development
119563
-30601
2023-04-13
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/12
1450000
-500000
2023-04-12
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/11
SVP, Clinical Development
119563
-30601
2023-04-11
0001725160
0001725160
88962